<DOC>
	<DOC>NCT01310270</DOC>
	<brief_summary>The hypothesis being tested is that in patients with stable claudication and documented PAD, omega-3 supplementation for 1 month will lead to improvement in endothelial function as measured by flow-mediated, brachial artery vasodilation (FMD), as well as improvement in the vascular inflammatory profile as measured by a panel of established circulating inflammatory biomarkers.</brief_summary>
	<brief_title>The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>intermittent claudication resting or exercise AnkleBrachial Index (ABI) &lt;0.9 age 50 and more critical limb ischemia hypersensitivity/allergies to fish or seafood already on omega3 fatty acids or equivalent significant renal, hepatic, and inflammatory disease concurrent severe infections acute illness (MI, stroke, major surgery within 30 days) receiving immunosuppressive medications or steroids</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>